deferoxamine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Madajewski, B | 1 |
Chen, F | 1 |
Yoo, B | 1 |
Turker, MZ | 1 |
Ma, K | 1 |
Zhang, L | 1 |
Chen, PM | 1 |
Juthani, R | 1 |
Aragon-Sanabria, V | 1 |
Gonen, M | 1 |
Rudin, CM | 1 |
Wiesner, U | 1 |
Bradbury, MS | 1 |
Brennan, C | 1 |
Suchaoin, W | 1 |
Chanvorachote, P | 1 |
2 other studies available for deferoxamine and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Deferoxamine; Drug De | 2020 |
Caveolin-1 attenuates hydrogen peroxide-induced oxidative damage to lung carcinoma cells.
Topics: Antioxidants; Carcinoma, Non-Small-Cell Lung; Caveolin 1; Cell Death; Cell Line, Tumor; Deferoxamine | 2012 |